TORONTO DOMINION BANK - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 11 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TORONTO DOMINION BANK ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2022$1,00076
+94.9%
0.00%
Q4 2021$039
+1200.0%
0.00%
Q3 2021$0
-100.0%
3
-99.6%
0.00%
Q2 2021$5,000842
+6916.7%
0.00%
Q1 2021$0120.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 131,731$508,0000.16%
SABBY MANAGEMENT, LLC 160,182$618,0000.12%
ZEKE CAPITAL ADVISORS, LLC 45,000$174,0000.01%
Freedom Investment Management, Inc. 16,339$63,0000.01%
Virtu Financial LLC 15,121$58,0000.00%
TORONTO DOMINION BANK 12$00.00%
ROYAL BANK OF CANADA 17$00.00%
UBS Group AG 632$2,0000.00%
OSAIC HOLDINGS, INC. 6,012$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders